Blue Horseshoe Stocks: HUGE Day on Friday & More

Recapping Our HUGE Day on Friday

We had winners cropping up all across the board on Friday, with our options idea, as well as a couple stocks from our watchlist all having really solid sessions to close out the week, the month, and the 2nd Quarter.

Nike, inc. NKE – We signaled our interest in a range of Nike calls, and were not disappointed in the results. Our targets were the 07/07 $55.50-57 Calls and they all posted considerable gains on the day.

$55.50 Calls – Range: 1.89-4.01 – Max Gain: 112%
$56 Calls – Range: .98-3.33 – Max Gain: 240%
$56.50 Calls – Range: .77-2.95 – Max Gain: 283%
$57 Calls – Range: .51-2.52 – Max Gain: 394%

NKE wasn’t the first set of options ideas we crushed last week. We also tagged contracts in the DRI and CBI chains that subsequently went on multi-bag runs. As always, we strive to deliver a varied range of ideas for traders, and options are a huge part of that.
____

Digital Power Corp. DPW – After tagging it in our watchlist in Friday’s premarket report, DPW had a very respectable intraday swing right out the gate that morning. The stock ran from a low of .65 and reached as high as 1.05, which represents a 62% pop.

The stock couldn’t sustain more than half of that gain into the close, however it is trading up slightly in the premarket today. We’ll want to continue to monitor this play, watching for the building of higher base levels of support over the course of this short and divided holiday week.
_____

ShiftPixy, Inc. PIXY – Speaking of solid runners from Friday’s report that are showing signs of bullish premarket activity today, we’ve also got PIXY, a stock that IPO’d on Friday. A close contact in our vast network of traders gave us the heads up on the commencement of trading in PIXY, and we took the opportunity to pass it along to our readers by including it in our watchlist.

We weren’t sorry that we did, as its first day of trading was very positive. From its opening price of 6.30, PIXY traded up to 7.74, for a respectable intraday rise of 23%, nearly all of which it held into the close. This morning, the stock is gapping up in the premarket, having already hit a new high of 8.48 and extended our observed range to 35%

We’re quite anxious to see how this new stock will progress from here, even if the timing of tomorrow’s holiday isn’t ideal. If PIXY continues to be a huge hit with the investment community, just remember, you heard it here first!


The Players Network PNTV

Given the fact that it streaked to new all time highs to close out the week on Friday, we want to swing back around to pat ourselves on the back heartily for PNTV.

We originally brought this stock to our readers back in October of last year, after which time the stock was trading for as little as .012. Flash forward to Friday of last week, and the stock has rocketed all the way to .127 marking an incredible increase of 958%

However, even if you’re newer to our reports and only caught our most recent alert on PNTV on June 13th, you still had the opportunity for profits of up to 34% as the range in that time span ran from .0951 to the new high of.127. With the stock firmly blue sky territory, there’s no telling where this ride will end up!

Additionally, Nevada’s recreational marijuana sales kicked off over the weekend, so that ramps up the intrigue with this play, considering the fact that the company was recently grated two licenses to supply recreational consumers in that state.


Extended Watchlist:
CARA, EYES, SPEX, NSPR, RATE, OPXA,

Blue Horseshoe Stocks: Week Kicks Off on High Note


Yesterday, despite the fact that the markets as a whole were on pace for the longest sustained backslide in more than half a decade, we still managed to see new highs in a few of the stocks we’ve been tracking.  We also observed solid intraday performances from a couple other plays that were on our morning watchlist, so we’ll begin today with a quick roundup of all these movers.

Dolat Ventures, Inc. DOLV

We signaled our interest in tracking DOLV in Thursday’s report, and at the time we’d witness the stock trading at a low of .0056.

Yesterday concluded with a new high, and the recording of three straight bullish sessions since then, with DOLV trading in an intraday range from .0125 to .019, for a gain of 52% It brings the updated figure on the three session swing we’ve seen so far to an impressive 239%


MyDx, Inc. MYDX

We circled back to MYDX, a stock we’ve tracked all the way from a February low of .001, last Wednesday, while it was trading as low as .0077. It too has put together a multi-day run leading to impressive new highs once again yesterday.

The stock saw a daily range of .017-.0226, which represents an increase of 32% on the day, 193% from last Wednesday’s low, and a ridiculous 2160% from our witnessed low in February!


U.S. Stem Cell, Inc. USRM

Here’s another stock whose low (.014) came during the month of February, following our report on the 27th. We’ve been all over it since then , and in two sustained bursts it has absolutely soared.

After reminding our readers of that fact in yesterday’s premarket report, USRM managed to hit yet another new high for us. It traded from .07-.112 for a daily boost of 60% and the new high recorded pushed our overall observed gain on this play in just one months time to an even 700%


Honorable Mentions

We placed a couple of plays in yesterday’s extended watchlist that didn’t blow our minds by any stretch of the imagination, but did log some solid intraday increases that warrant continued observation for each of them.

Catalyst Pharmaceuticals, Inc. CPRX
Daily Range: 1.63-2.07 – Max Gain: 27%

Impax Laboratories, Inc. IPXL
Daily Range: 10.50-13.00 – Max Gain: 24%


Extended Watchlist:
BRSE, OWCP, CARA, NVIV, SHIP, SSH, SBLK

Blue Horseshoe Stocks: BIND Recap & More

BIND Therapeutics, Inc. BIND

BIND cropped up on our premarket scanner yesterday in the wake of a post-market PR on Wednesday afternoon, and it put forth a solid move early in the session. It traded as low as 7.40 at the open, and we then witnessed a significant 36% spike to the high-of-day at 10.04.

That initial run was fueled by the release of positive Phase-2 results from one of the company’s many cancer treatments currently in various trial phases, and additionally, an update on guidance for 2015.  >>> READ PR

According to the CEO, BIND expects 2015 “to be a particularly active period” with regard to the development of its many products, so this will be a play that we’ll want to monitor more closely moving forward.

Toward the end of the session yesterday BIND pulled back, and is gapping once again in the pre-market, so we have our eyes peeled for any potential bounce action that could be used in our favor.


Twitter, Inc. TWTR – Options

We’ve also got to update everyone on the options trading idea we put forth earlier this week for TWTR. We mentioned an interest in the Weekly $38 and $39 Calls, and each set of contracts showed us a huge spike during yesterday’s session.

The $38’s traded in a range from .23-1.22, for a chance at monstrous gains of up to 430%, while the $39’s did even better as they ripped from .09 to a high of .54, a move totaling 500%

We also wanted to remind readers of the long-term options idea for TWTR we mentioned in the same report. The February $40 Calls could be in line for significant gains if TWTR continues to recover off of recent lows in the $35-36 range.


Extended Watchlist:
AGEN, CERE, ARNA, SD, NVAX, CARA